Moderna legal chief sells 3,471 shares at $139.95
Moderna’s chief legal officer exercised options, converted RSUs, and sold shares in pre-planned trades while retaining significant option and RSU holdings.
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) reported that Chief Legal Officer Shannon Thyme Klinger exercised stock options and settled restricted stock units on September 1, 2026. She exercised 3,471 options at $30.96 per share into common stock and sold 3,471 shares at $139.95 per share under a Rule 10b5-1 trading plan adopted on September 9, 2025. In addition, 2,166 restricted stock units converted into common stock on a one-for-one basis, and 1,048 shares were withheld to satisfy tax withholding obligations in connection with RSU vesting. Following these transactions, she continued to hold 34,716 stock options and 21,661 restricted stock units directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Klinger Shannon Thyme
Role
Chief Legal Officer
Sold
3,471 shs ($486K)
Approx. gross sale proceeds
$486K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F4 | 3,471 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F2, F5 | 2,166 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 3,471 | $30.96 | $107K |
| Sale | Common Stock F1 | 3,471 | $139.95 | $486K |
| Exercise | Common Stock F2 | 2,166 | -- | -- |
| Tax Withholding | Common Stock F3 | 1,048 | $140.34 | $147K |
Holdings After Transaction:
Stock Option (Right to Buy) — 34,716 contracts (Direct);
Restricted Stock Units — 21,661 contracts (Direct);
Common Stock — 75,247 shares (Direct)
Footnotes (5)
- F1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025.
- F2. Restricted stock units convert into common stock on a one-for-one basis.
- F3. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F4. 25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- F5. 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Key Figures
Options exercised: 3,471 shares
Option exercise price: $30.96 per share
Shares sold: 3,471 shares
+5 more
8 metrics
Options exercised
3,471 shares
Stock options exercised into common stock on September 1, 2026
Option exercise price
$30.96 per share
Exercise price for 3,471 stock options
Shares sold
3,471 shares
Common stock sold on September 1, 2026
Sale price
$139.95 per share
Per-share price for 3,471 shares of common stock sold
RSUs converted
2,166 units
Restricted stock units converting into common stock on a one-for-one basis
Shares withheld for taxes
1,048 shares
Shares withheld to satisfy tax withholding obligations on RSU vesting
Options held after transaction
34,716 options
Stock options remaining following the reported exercise
RSUs held after transaction
21,661 units
Restricted stock units remaining after RSU conversion and vesting
Key Terms
Rule 10b5-1 trading plan, Restricted stock units, tax withholding obligations, vested, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Restricted stock units financial
"Restricted stock units convert into common stock on a one-for-one basis"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"shares withheld at the election of the Reporting Person to satisfy tax withholding obligations"
vested financial
"shares subject to this restricted stock unit award vested on March 1, 2026"
stock option financial
"25% of this option vested and became exercisable on March 1, 2026"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What did Moderna (MRNA) disclose about Shannon Thyme Klinger's latest Form 4 transactions?
The filing reports that Chief Legal Officer Shannon Thyme Klinger exercised 3,471 stock options, converted 2,166 RSUs into common stock, sold 3,471 shares, and had 1,048 shares withheld for taxes on September 1, 2026, all in direct holdings.
At what price were Shannon Thyme Klinger's Moderna (MRNA) stock options exercised?
She exercised 3,471 stock options into common stock at an exercise price of $30.96 per share on September 1, 2026, with the options originally vesting beginning March 1, 2026.
How many Moderna (MRNA) restricted stock units vested or converted for Shannon Thyme Klinger?
A total of 2,166 restricted stock units converted into Moderna common stock on a one-for-one basis as part of an RSU award that began vesting on March 1, 2026.
Were Shannon Thyme Klinger's Moderna (MRNA) trades under a Rule 10b5-1 plan?
Yes. The Form 4 states the reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025, indicating the trades were pre-arranged under that plan.
How many Moderna (MRNA) derivative awards does Shannon Thyme Klinger hold after these transactions?
After the reported transactions, she holds 34,716 stock options and 21,661 restricted stock units, all reported as directly owned derivative securities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
